Effects of insulin-like growth factor I (IGF-I) and salmon gonadotropin-releasing hormone (sGnRH) on expression of gonadotropin (GTH) subunit genes were examined using primary pituitary cell cultures of masu salmon (Oncorhynchus masou). Fishes were assessed at three reproductive stages, i.e., in April (early maturation), in June (maturing), and in September (spawning). Amounts of GTH subunit mRNAs in pituitary cells were determined using real-time PCR after incubation with IGF-I and/or sGnRH. IGF-I alone had almost no effects on three GTH subunit mRNAs in both sexes, except for decrease in follicle-stimulating hormone (FSH) β mRNA in males in June. sGnRH alone was effective in stimulation of FSHβ and luteinizing hormone (LH) β gene expression in males in April. Thereafter it had no significant effects on GTH subunit mRNAs, although in September it tended to increase FSHβ and LHβ mRNAs in females. Co-administered IGF-I counteracted the sGnRH-induced expression of FSHβ and LHβ genes in males in April, but not in females in September. These results suggest that IGF-I is involved in direct regulation of GTH subunit genes during sexual maturation. In particular, IGF-I differently modulates sGnRH-induced GTH subunit gene expression, depending on reproductive stages.
Introduction
Several lines of evidence showed that insulin-like growth factor-I (IGF-I) played a pivotal role in interactions between somatotropic and gonadotropic axes. IGF-I has metabolic and mitogenic activities, and acts as a mediator of somatotropic actions of growth hormone. In addition, it activated directly the hypothalamic-pituitary-gonadal axis to promote onset of puberty (Hiney et al., 1991 (Hiney et al., , 1996 Huang et al., 1998) . IGF-I stimulated the release of gonadotropin-releasing hormone (GnRH) in rats at puberty, and GnRH in turn elevated plasma thought to act as a signaling molecule that transmits growth and nutritional status to the gonadotropic axis at the onset of puberty. However, little is known about its mechanisms of action in functional interactions with GnRH to control GTH production. In particular, no information is available on effects of IGF-I on expression of GTH subunit genes in teleosts.
Expressions of GTH subunit genes vary during reproductive cycles in salmonids.
Amounts of their mRNAs increased with sexual maturation, and considerably rose at spawning (Gomez et al., 1999; Kitahashi et al., 2004) . In masu salmon, FSHβ mRNA started to increase at early stages of gametogenesis in March, whereas LHβ mRNA started to increase at a later stage of gametogenesis in June (Kitahashi et al., 2004) . GnRH has been shown to influence GTH subunit gene expression in a subunit-and reproductive stage-dependent manner (Kitahashi et al., 1998b; Dickey and Swanson, 2000; Ando et al., 2004; Ando and Urano, 2005) . In masu salmon, GnRH analog (GnRHa) that was implanted into the dorsal muscle increased GPα2 and LHβ mRNAs in June onwards, while it had no effects on FSHβ mRNA during sexual maturation (Kitahashi et al., 2004) . Therefore, sGnRH has a pivotal role in increasing expressions of LH subunit genes during sexual maturation. However, mechanisms underlying the earlier increase of FSHβ gene expression remain unknown.
One of the candidates responsible for upregulation of FSHβ gene expression is IGF-I as described above. Therefore, we examined effects of IGF-I alone and in combination with sGnRH on expression of GTH subunit genes using masu salmon pituitary cell cultures. Since responses to IGF-I and sGnRH were expected to depend on reproductive stages, pituitary cell cultures were prepared from fishes at three different reproductive stages, i.e., early maturation in April, maturing stage in June, and spawning in September. Levels of plasma sex steroid hormones were also determined using enzyme immunoassays to confirm levels of sexual maturation in the experimental fishes.
Materials and methods

1. Experimental design
On the basis of our previous studies in which the effects of sGnRH on expression of GTH subunit genes were clarified (Ando and Urano, 2005), we carried out three experiments to examine effects of IGF-I, sGnRH, and E2 on GTH subunit gene expression. In experiment I, effects of different doses of IGF-I (1, 10, 100 nM) alone or in combination with sGnRH (100 nM) were examined in female fishes in April. Cells were incubated with these hormones for 1 day. In experiment II, the kinetics of effects of IGF-I (100 nM) and sGnRH (100 nM) were examined in male and female fishes in April. Cells were incubated with appropriate hormones for 1, 2, and 3 days. In experiment III, seasonal changes in effects of IGF-I (100 nM) and sGnRH (100 nM) at three days after treatment were examined in males in June and in females in June and September. Because of limited number of fish available, we could not examine the effects in males in experiment I and in September in experiment III.
Fishes
Experiment I was conducted in April 2002 using masu salmon of the Shiribetsu strain, reared at the Kumaishi branch of Hokkaido Fish Hatchery; and experiments II and III were conducted in April, June, and September 2002, using the Mori hatchery strain reared at the Mori branch of Hokkaido Fish Hatchery. Fishes of both strains retained the ability of homing migration, nonetheless they could grow, mature, and spawn in a freshwater environment. In our previous experiments in 2001, levels of GTH subunit mRNAs in pituitary cells from the two strains showed similar changes during sexual maturation and also in response to sGnRH and sex steroid hormones (Ando et al. 2004 ).
Fishes were maintained in outdoor tanks with a flow of spring water (8 o C in experiment I, and 9-14 o C in experiments II and III) under natural photoperiod. They were fed with dry pellets equivalent to 1.7-2 % of body weight every two days until the end of July, after which they did not eat any more. Under these conditions, gonadal development was initiated in spring, and the Shiribetsu strain at the Kumaishi branch spawned in late September, and the Mori hatchery strain at the Mori branch spawned in early September.
culture medium to obtain appropriate final concentrations, and immediately used in experiments.
5. Primary cell culture
Preparation of primary pituitary cultures was described previously (Ando et al., 2004) .
Pooled pituitaries were minced with a surgical blade, and transferred to RPMI medium containing 20 mM HEPES, 9 mM sodium bicarbonate, penicillin (100 U/ml), streptomycin (100 U/ml), and fungizone (0.25 mg/ml), supplemented with 0.1 % collagenase (GIBCO Invitrogen Corp., Carlsbad, CA) and 3 % bovine serum albumin (BSA, GIBCO Invitrogen
Corp.). After incubation at 12 o C for 20 h, cells were mechanically dissociated by aspiration for several times through a pipette. Then, they were washed twice with RPMI medium supplemented with Serum Replacement 2 (1x), which did not contain steroid hormones, glucocorticoids, and growth factors (Sigma-Aldrich, Tokyo, Japan). We verified that Serum Replacement 2 had no effects on the basal expression of GTH subunit mRNAs (data not shown). Dispersed cells were immediately plated on 12-well polylysine-coated culture plates at a density of 3 x 10 5 cells/1.3 ml medium/well (n = 3-6), and were incubated at 18 o C for 2 days.
Then, medium was changed, and hormones were included into the fresh medium. Cells were successively incubated for 1-3 days as described above. After incubation, the medium was removed, and cells were harvested by scraping in 0.7 ml of medium twice, then collected by centrifugation at 5,000 rpm for 10 min, frozen at -80 o C until assayed by real-time PCR for GTH subunit mRNAs.
6. Quantitation of GTH subunit mRNAs by real-time PCR
RNA extraction, reverse transcription (RT), and real-time PCR were previously described in details by Ando et al. (2004 To determine absolute amounts of GTH subunit mRNAs, standard sense RNAs were synthesized in vitro by MAXIscript (Ambion Inc, Texas) using GPα2, FSHβ, and LHβ cDNAs (Sekine et al. 1989) , and they were used for RT reactions to prepare standard cDNAs. In each assay, a standard sample (chum salmon pituitary cDNA) was subjected to amplification in triplicates to estimate coefficients of variation (CV) within and between runs.
For GPα2 assay, intra-assay CV was 7.2 ± 1.3 %, and inter-assay CV was 13 %; for FSHβ assay, intra-assay CV was 5.5 ± 1 %, and inter-assay CV was 11.8 %. Finally, for LHβ assay, intra-assay CV was 6 ± 1 %, and inter-assay CV was 8.8 %.
7. Assays of plasma steroid hormones
Plasma levels of E2, testosterone (T), 11-ketotestosterone (11-KT), and 17α,20β-dihydroxy-4-pregnen-3-one (DHP) were determined by enzyme immunoassays as described in details by Onuma et al. (2003) . In brief, ether-extracted samples were dissolved in assay buffer containing 0.2 % bovine serum albumin, 0.01 % thimerosal in 0.05 M borate buffer, pH 7.8. Standard hormones and samples were incubated with anti-steroid antiserum and HRP-labeled steroid (Cosmo Bio, Tokyo) in wells of 96 well microtiter plates (Sumitomo Bakelite, Tokyo), in which anti-rabbit IgGs (ICN Pharmaceuticals, Aurora) were immobilized by physical adsorption. Following an overnight incubation at 4 o C, wells were washed with 0.9 % NaCl, and a substrate solution (0.5 g/l o-phenylenediamine, 0.01 % H 2 O 2 in 0.2 M citrate buffer, pH 4.5) was added, and mixed solutions were incubated at room temperature for 30 min. Then, optical densities at 492 nm were measured using a microplate reader (MTP-300, Corona Electric, Hitachinaka). Sensitivities of assays were: E2, 0.5 pg/tube; T, 1.5 pg/tube; 11-KT, 1.5 pg/tube; and DHP, 0.5 pg/tube. Intra-assay CVs were: E2, 4.5 ± 0.9 %; T, 6.6 ± 2 %; 11-KT, 2.6 ± 0.5 %; and DHP, 3.9 ± 1.3 %. Inter-assay CVs were: E2, 7 %; T, 13.3 %; 11-KT, 9.8 %; and DHP, 14.6 %.
8. Statistical analysis
Data were presented as means ± SEM. In experiment I, the Games-Howell's multiple comparisons test was applied to test for statistically significant differences of GTH subunit mRNAs after incubation with IGF-I and/or sGnRH. In experiment II, statistical analysis of the effect of time of incubation was performed by ANOVA. In experiment II and III, the effects of IGF-I and/or sGnRH were tested by the Dunnett's pairwise multiple comparison t-test. The basal expression levels of GTH subunit genes in female control cells and plasma steroid levels in both sexes were analyzed by ANOVA to test for differences among months; and when appropriate, the Tukey's post hoc test was applied. GTH mRNAs in males were analyzed by a Student t-test for statistically significant differences between April and June. Statistical analyses were performed using SPSS Version 12.0 for Windows (SPSS Inc., Chicago, IL).
September.
Discussion
The present study examined in vitro effects of IGF-I in combination with sGnRH on expression of GTH subunit genes in masu salmon pituitary cells at three stages of sexual maturation. Our results suggested that IGF-I is directly involved in regulation of expression of three GTH subunit genes at particular stages in both sexes. IGF-I alone had no stimulatory effects during sexual maturation, but had an inhibitory effect of IGF-I on FSHβ mRNA in males in June. Furthermore, IGF-I differentially modulated sGnRH-induced expression of GTH subunit genes. In particular, our results clearly showed that these effects were dependent on reproductive stages.
These findings are the first evidence for the effects of IGF-I on expressions of FSHβ and LHβ subunit genes in any vertebrates, although there were many studies reporting stimulatory effects of IGF-I on FSH and LH contents and release in mammals (Kanematsu, et al., 1991; Soldani et al., 1994 Soldani et al., , 1995 Xia et al., 2001; Hashizume et al., 2002) and fishes (Huang et al., 1998 (Huang et al., , 1999 Weil et al., 1999; Baker et al., 2000) , and on expression of α subunit gene in rats (Pazos et al., 2004) .
A dose of IGF-I at 100 nM was used in experiments II and III. Although this dose seems to be high, it was chosen because of the following reasons. Similar and even higher doses of IGF-I were previously demonstrated by other authors to stimulate FSH and LH release with high efficiency based on dose-response experiments. In coho salmon pituitary cells, 10-day pre-incubation with IGF-I at 100 nM was most effective for intracellular accumulations of FSH and LH, and for potentiation of GnRH-stimulated FSH release (Baker et al., 2000) . IGF-I at 1 μM was effective to sensitize rainbow trout pituitary cells to GnRH in terms of releases of FSH and LH (Weil et al., 1999) . Similarly, European eel pituitary cells maximally responded to IGF-I at the concentration of 100 nM in LH release and cell content (Huang et al., 1998 (Huang et al., , 1999 .
In addition, the present dose of IGF-I was of similar order to circulating levels in salmonids. Plasma levels of total IGF-I in coho salmon were 50-250 ng/ml, that is 6.5-32.5 nM (Moriyama et al., 1994) . Thus, the present dose of IGF-I was 3 times the maximum circulating level. In fact, at concentrations in the range of 4-250 ng/ml, salmon IGF-I significantly stimulated sulfate uptake by cultured branchial cartilages of coho salmon (Moriyama et al., 1993) . Also it should be noted that human recombinant IGF-I, but not salmon IGF-I, was used in the present study. Human IGF-I and salmon IGF-I were equipotent in stimulating sulfate uptake in salmon branchial cartilages (Moriyama et al., 1993) . Receptor binding studies sGnRH (100 nM) at 2 days after plating and successively incubated for 1 day. After incubation, cells were collected, and the amounts of GTH subunit mRNAs were assayed by real-time PCR.
Results are expressed as mean ± SEM. No statistically significant changes in three GTH subunit mRNAs were observed in response to any combination of hormones (Games-Howell's test, P < 0.05). . Cells were treated with IGF-I (100 nM) with or without sGnRH (100 nM) at 2 days after plating and successively incubated for 1, 2, and 3 days. After incubation, cells were collected, and the amounts of GTH subunit mRNAs were assayed by real-time PCR.
Results are expressed as mean ± SEM. No statistically significant changes in three GTH subunit mRNAs were observed during the three days of incubation (ANOVA, P < 0.05) and in response to hormones (Dunnett's pairwise multiple comparison t-test, P < 0.05). Results are expressed as mean ± SEM. Asterisks denote significant difference between the control (without hormones) and hormone-treated groups (* P < 0.05, Dunnett's pairwise multiple comparison t-test). Results are expressed as mean ± SEM. Asterisks denote significant difference between the control (without hormones) and hormone-treated groups (* P < 0.05, Dunnett's pairwise multiple comparison t-test). 
